The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
Chronic kidney disease: effects on the cardiovascular system.
Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.
NADPH oxidases in the kidney.
Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.
Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production.
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
Letter: Nomogram for Bayes theorem.
Racial differences in the incidence of treatment for end-stage renal disease.
CLINICAL AND RADIOLOGICAL FEATURES OF URINARY INFECTION IN CHILDHOOD.
Glomerular number and size in autopsy kidneys: the relationship to birth weight.
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.
Circulation: overall regulation.
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.